The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus

Overview of attention for article published in Journal of Rheumatology, August 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 26 patents

Citations

dimensions_citation: 104 Dimensions

Readers on

mendeley: 55 Mendeley

So far, Altmetric has seen 26 patents that reference this research output.

The Journal of Rheumatology

Article Metrics

The Relation of Interleukin 17 (IL-17) and IL-23 to Th1/Th2 Cytokines and Disease Activity in Systemic Lupus Erythematosus

About this Attention Score

Mentioned by

Citations

Readers on

Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare

Grant US-11585810-B2

United States of America

Bicyclic bromodomain inhibitors

Grant US-11446306-B2

United States of America

Substituted bicyclic compounds as bromodomain inhibitors

Grant US-11026926-B2

United States of America

Bicyclic bromodomain inhibitors

Grant US-10772892-B2

United States of America

Substituted pyridinones as bromodomain inhibitors

Grant US-10710992-B2

United States of America

NOVEL BICYCLIC BROMODOMAIN INHIBITORS

Application EP-3674300-A1

European Patent Office

Quinazolinones as bromodomain inhibitors

Grant US-10500209-B2

United States of America

Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare

Grant US-10393739-B2

United States of America

Bicyclic bromodomain inhibitors

Grant US-10363257-B2

United States of America

Substituted heterocycles as bromodomain inhibitors

Grant US-10292968-B2

United States of America

Inhibitors of bromodomains

Grant US-10231953-B2

United States of America

Substituted bicyclic compounds as bromodomain inhibitors

Grant US-10226451-B2

United States of America

Substituted pyridines as bromodomain inhibitors

Grant US-10179125-B2

United States of America

Substituted bicyclic compounds as bromodomain inhibitors

Grant US-10166215-B2

United States of America

Bicyclic bromodomain inhibitors

Grant US-10010556-B2

United States of America

Heterocyclic compounds as bromodomain inhibitors

Grant US-9861637-B2

United States of America

Quinazolinones as bromodomain inhibitors

Grant US-9855271-B2

United States of America

Biaryl derivatives as bromodomain inhibitors

Grant US-9765039-B2

United States of America

Bicyclic bromodomain inhibitors

Grant US-9663520-B2

United States of America

Substituted bicyclic compounds as bromodomain inhibitors

Grant US-9662311-B2

United States of America

Substituted bicyclic compounds as bromodomain inhibitors

Grant US-9636328-B2

United States of America

Heterocyclic compounds as bromodomain inhibitors

Grant US-9598367-B2

United States of America

Treatment for nephritis

Grant US-9295705-B2

United States of America

Cyclic amines as bromodomain inhibitors

Grant US-9278940-B2

United States of America

Heterocyclic compounds as bromodomain inhibitors